Form 4 for CYTK CYTOKINETICS INC
Accepted 2025-04-21 00:00:00 ET · period of report 2025-04-21 · accession 0001127602-25-012398 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-04-21 | 2025-04-21 | CYTK | WIERENGA WENDALL | Dir | S - Sale+OE | $38.46 | -20.0K | 24.8K | -45% | -$769.2K |
| D | 2025-04-21 | 2025-04-21 | CYTK | WIERENGA WENDALL | Dir | M - OptEx | $6.21 | +20.0K | 44.8K | +80% | +$124.2K |
| D | 2025-04-21 | 2025-04-21 | CYTK | WIERENGA WENDALL | Dir | M - OptEx | $0.00 | -20.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-21 | S | D | 20,000 | $38.46 | 24,848 | D | — | — | |
| 2 | Common | Common Stock | 2025-04-21 | M | A | 20,000 | $6.21 | 44,848 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-04-21 | M | D | 20,000 | $0.00 | 0 | D | $6.21 · 2015-06-22 to 2025-05-20 | 20,000 Common Stock | (F1) This option shall vest and become exercisable in 12 equal monthly installments and shall become fully vested on May 20, 2016. |